References
- Soriano-Gabarro M, Mrukowicz J, Vesikari T, et al. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006;25(Suppl 1):S7-11
- Verstraeten T, Wolleswinkel-van den Bosch. Burden of Rotavirus Disease in the new European Union. Poster 3rd Annual Meeting of the European Society for Paediatric Infectious Diseases, May 18-20 2005
- Parashar UD, Hummelman EG, Bresee JS, et al. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565-72
- Jit M, Pebody R, Chen M, et al. Estimating the number of deaths with rotavirus as a cause in England and Wales. Hum Vaccin 2007;3:23-6
- Harris JP, Jit M, Cooper D, et al. Evaluating rotavirus vaccination in England and Wales. Estimating the burden of disease. Vaccine 2007;15:3962-70
- Van Damme P, Giaquinto C, Huet F, et al. REVEAL Study Group. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis 2007;195:(Suppl 1):S4-16
- Gleizes O, Desselberger U, Tatochenko V, et al. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J 2006;25(1 Suppl):S12-21
- Frühwirth M, Heininger U, Ehlken B, et al. International variation in disease burden of rotavirus gastroenteritis in children with community- and nosocomially acquired infection. Pediatr Infect Dis J 2001;20:784-91
- NICE Clinical Guidelines. CG84 Diarrhoea and vomiting caused by gastroenteritis diagnosis, assessment and management in children younger than 5 years. London: NICE, 2007 (Last accessed 12th February 2010)
- http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4140197 (Last accessed 19th February 2010)
- Wheeler JG, Sethi D, Cowden JM, et al. On behalf of the Infectious Intestinal Disease Study Executive. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. BMJ. 1999;318:1046-50.
- http://www.dh.gov.uk/en/Publicationsandstatistics/Statistics/Performancedataandstatistics/Beds/DH_083781 (Last accessed 12th February 2010)
- http://www.isdscotland.org/isd/3426.html (Last accessed 12th February 2010)
- Mast TC, DeMuro-Mercon C, Kelly CM, et al. The impact of rotavirus gastroenteritis on the family. BMC Pediatr 2009;9:11
- Giaquinto C, Van Damme P, Huet F, et al. REVEAL Study Group. Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study. J Infect Dis 2007;195(Suppl 1):S36-44
- Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22
- Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33
- WHO position paper, 2007
- Vesikari T, Van Damme P, Giaquinto C et al. Expert Working Group; European Society for Paediatric Infectious Diseases; European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary. J Pediatr Gastroenterol Nutr 2008;46:615-18
- Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010;125:199-207
- Wang FT, Mast TC, Glass RJ, et al. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics 2010;125:208-13